A detailed history of Integrated Wealth Concepts LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Integrated Wealth Concepts LLC holds 21,960 shares of TGTX stock, worth $680,760. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,960
Previous 6,285 249.4%
Holding current value
$680,760
Previous $226,000 250.88%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$26.39 - $39.19 $413,663 - $614,303
15,675 Added 249.4%
21,960 $793,000
Q2 2025

Aug 14, 2025

BUY
$33.37 - $45.51 $209,730 - $286,030
6,285 New
6,285 $226,000
Q4 2021

Feb 15, 2022

SELL
$15.2 - $35.51 $97,249 - $227,192
-6,398 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$21.78 - $40.45 $139,348 - $258,799
6,398 New
6,398 $213,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.5B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.